HSD17B14 and neoplasm: However, elevated HSD17B14 expression has been associated with poor survival in women with ER-positive breast cancer, and a high estrone (E1):17β-estradiol (E2) ratio in postmenopausal women has been shown to drive inflammation and stimulate ER-positive breast cancer tumor growth [41].